← Open Payments lookup

JO DRENNAN: Open Payments

NPI 1326659772 · BILOXI, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,230 in 136 payments from 14 companies in 2025. Trend: 2023 $143 · 2024 $247 · 2025 $3,230

Food & beverage: $3,181Education: $49
CompanyPaymentsAmount
Axsome Therapeutics, Inc.27$719
Janssen Pharmaceuticals, Inc30$470
ABBVIE INC.19$412
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)9$294
Vanda Pharmaceuticals Inc.10$250
Teva Pharmaceuticals USA, Inc.9$246
Takeda Pharmaceuticals U.S.A., Inc.11$201
Lundbeck LLC7$146
Boston Scientific Corporation1$125
VERTEX PHARMACEUTICALS INCORPORATED1$120

Products named: Auvelity, VRAYLAR, SPRAVATO, CAPLYTA, FANAPT, TRINTELLIX, AUSTEDO XR, Intracept.

Industry payments across MS — which companies pay providers there.